Current Pharmaceutical Design
Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
   |
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research
Contents
Current Pharmaceutical Design, Volume 17 - Number 2
Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
, 17(2): 94 - 102Shigeyuki Chaki and Hirohiko Hikichi
DOI: 10.2174/138161211795049570
Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
, 17(2): 103 - 111Dana V. Ferraris and Takashi Tsukamoto
DOI: 10.2174/138161211795049633
α7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia
, 17(2): 121 - 129Masatomo Ishikawa and Kenji Hashimoto
DOI: 10.2174/138161211795049561
Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
, 17(2): 130 - 136Norbert Muller, Aye-Mu Myint and Markus J. Schwarz
DOI: 10.2174/138161211795049552
PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia
, 17(2): 137 - 150Jan Kehler and Jacob Nielsen
DOI: 10.2174/138161211795049624
Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
, 17(2): 151 - 167Silvia Paba, Roberto Frau, Sean C. Godar, Paola Devoto, Francesco Marrosu and Marco Bortolato
DOI: 10.2174/138161211795049589
Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia
, 17(2): 168 - 175Motoko Maekawa, Yuji Owada and Takeo Yoshikawa
DOI: 10.2174/138161211795049615
MicroRNAs: A Novel Therapeutic Target for Schizophrenia
, 17(2): 176 - 188Javier A. Bravo and Timothy G. Dinan
DOI: 10.2174/138161211795049543
Editor-in-Chief
William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)
Biography
View Full Editorial Board
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
Biography
Biography of William A. Banks
Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32
Advertisement
Webmaster Contact: info@benthamscience.net